| Financial Year |
March 31 2023 |
| Monetary Funds |
97,307,847,114.56 |
| Held-for-trading Financial Assets |
142,736,922.09 |
| Notes Receivable |
20,669,089.41 |
| Accounts Receivable |
4,951,385,555.87 |
| Advances to Suppliers |
3,859,585,550.89 |
| Other Receivables |
130,935,090,906.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
74,641,446.91 |
| Inventories |
417,011,461,484.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,297,586,091.92 |
| Total Current Assets |
680,540,149,715.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
24,789,234.59 |
| Long-term Equity Investment |
74,746,814,455.09 |
| Investment Properties |
121,155,668,991.10 |
| Fixed Assetes |
10,694,290,655.97 |
| Under-construction Projects |
839,772,448.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,370,190,806.59 |
| R&D expenses |
88,135,149.67 |
| Goodwill |
2,013,388,206.90 |
| Long-Term Deferred and Prepaid Expenses |
1,063,998,907.60 |
| Deferred Income Tax Assets |
16,766,736,237.14 |
| Other Non-Current Assets |
479,287,820.37 |
| Sub-Total of Non-Current Assets |
232,823,020,735.41 |
| Total Assets |
913,363,170,450.95 |
| Short-Term Loans |
1,615,536,186.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
76,678,682.60 |
| Accounts Payable |
46,411,347,559.26 |
| Accounts Received In Advance |
173,100,771.91 |
| Employee Compensation Payable |
1,331,735,057.80 |
| Taxes Payable |
9,816,097,787.18 |
| Interest Payable |
-- |
| Dividend Payable |
597,621,548.16 |
| Other payables |
132,839,656,175.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
42,663,667,677.94 |
| Other Current Liabilities |
39,499,277,336.31 |
| Sub-Total of Current Liabilities |
448,119,457,169.76 |
| Long-term Loans |
127,642,700,353.98 |
| Bonds Payable |
38,248,000,000.00 |
| Long-Term Accounts Payable |
4,052,900,578.42 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,862,474.50 |
| Deferred Income Tax Liabilities |
2,705,678,672.39 |
| Other Non-Current Liabilities |
4,059,001,454.05 |
| Sub-Total of Non-Current Liabilities |
182,905,287,197.15 |
| Total Liabilities |
631,024,744,366.91 |
| Paid-In Capital(Or Share Stock) |
7,739,098,182.00 |
| Capital Surplus |
10,213,669,540.03 |
| Surplus Reserve |
4,192,128,386.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
60,886,358,300.13 |
| Minority Stockholder's Interest |
181,344,996,168.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
100,993,429,915.27 |
| Owner's Equity（Stockholder's Equity） |
282,338,426,084.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
913,363,170,450.95 |
